NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies; Board on Health Care Services; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine; Graig LA, Phillips JK, Moses HL, editors. Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine. Washington (DC): National Academies Press (US); 2016 Jun 30.
Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine.
Show details- HAROLD L. MOSES (Chair), Ingram Professor of Cancer Research, Professor and Chair, Department of Cancer Biology, Professor of Medicine and Professor of Pathology, Microbiology, and Immunology, Director-Emeritus, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University Medical Center
- JOHN M. CARETHERS, John G. Searle Professor and Chair, Department of Internal Medicine, Professor of Human Genetics, University of Michigan Health System
- MOLLY COOKE, Professor of Medicine and Director of Education, Global Health Sciences, University of California, San Francisco
- GARRET A. FITZGERALD, Professor of Medicine and Pharmacology, McNeil Professor in Translational Medicine and Therapeutics, Chair, Department of Pharmacology, Director, Institute for Translational Medicine & Therapeutics, Perelman School of Medicine, University of Pennsylvania
- FELIX W. FRUEH, Executive Partner, Opus Three LLC
- DEBRA LEONARD, Professor and Chair of Pathology & Laboratory Medicine, University of Vermont Medical Center, University of Vermont College of Medicine
- GARY H. LYMAN, Co-Director, Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Professor of Medicine, Public Health, and Pharmacy, University of Washington ROBERT L. NUSSBAUM, Chief Medical Officer, Invitae; Professor Emeritus and Volunteer Clinical Professor, University of California San Francisco School of Medicine
- REBECCA D. PENTZ, Professor of Research Ethics, Winship Cancer Institute, Emory University School of Medicine EDITH A. PEREZ,1 Vice President and Head of the BioOncology Medical Unit, US Medical Affairs, Genentech; Deputy Director at Large, Mayo Clinic Cancer Center, Director, Breast Cancer Translational Genomics Program, Serene M. and Frances C. Durling Professor of Medicine, Division of Hematology/Oncology, Mayo Clinic
- JANE PERLMUTTER, Independent Consultant, Gemini Group
- VICTORIA M. PRATT, Director, Pharmacogenomics Laboratory, Department of Medical and Molecular Genetics, Indiana University School of Medicine
- YU SHYR, Harold L. Moses Chair in Cancer Research, Director, Vanderbilt Center for Quantitative Sciences, Director, Vanderbilt Technologies for Advanced Genomics, Analysis and Research Design, Professor, Department of Biostatistics, Biomedical Informatics, Cancer Biology, and Health Policy, Vanderbilt University
- SEAN TUNIS, Founder, President and CEO, Center for Medical Technology Policy
- TRACEY F. WEISBERG, President, New England Cancer Specialists
Study Staff
- LAURENE GRAIG, Study Director
- JONATHAN PHILLIPS, Research Associate
- SARAH E. DE LEO, Christine Mirzayan Science and Technology Policy Graduate Fellow (from January to July 2015)
- NOA NIR, Senior Program Assistant (from April 2015)
- CELYNNE BALATBAT, Senior Program Assistant (until April 2015)
- PATRICK BURKE, Financial Associate
- SHARYL NASS, Director, National Cancer Policy Forum; Director, Board on Health Care Services
- ADAM C. BERGER, Director, Roundtable on Translating Genomic-Based Research for Health (until August 2015)
- ANDREW M. POPE, Director, Board on Health Sciences Policy
Footnotes
- 1
Through August 2015.
- COMMITTEE ON POLICY ISSUES IN THE CLINICAL DEVELOPMENT AND USE OF BIOMARKERS FOR...COMMITTEE ON POLICY ISSUES IN THE CLINICAL DEVELOPMENT AND USE OF BIOMARKERS FOR MOLECULARLY TARGETED THERAPIES - Biomarker Tests for Molecularly Targeted Therapies
Your browsing activity is empty.
Activity recording is turned off.
See more...